VINCOV-19
-
VINS Bioproducts receives DCGI approval
To commence the clinical trials for VINCOV-19, an antidote, and a cure against COVID-19 VINS Bioproducts, a leading immunological company,…
Read More »
To commence the clinical trials for VINCOV-19, an antidote, and a cure against COVID-19 VINS Bioproducts, a leading immunological company,…
Read More »